Associate Director, B2B CMH at Eli Lilly and Company

Toronto, Ontario, Canada

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Extensive experience in senior-level key account and business-to-business management
Familiarity with retail pharmacy chains and key HCP accounts
Understanding of online/telehealth platforms (an asset)
Experience in private healthcare insurance (a plus)
Entrepreneurial mindset with strong commercial acumen
Effective communication skills and a proven track record of business growth in the healthcare market
Commitment to ethical conduct
Strategic thinking and an out-of-the-box mindset
Strong analytical skills and the ability to interpret complex data to define overarching strategies and build performance dashboards
Ability to identify untapped opportunities

Responsibilities

Identify and map private business opportunities across provinces and the country
Lead the development and execution of strategic business plans, leveraging deep industry experience, strategic foresight, and an innovative mindset
Build and maintain relationships with key stakeholders, including wholesalers, pharmacy chains/associations/digital health care, and key health care providers including out-patient care centers, specialized centers, and practice networks
Ensure product accessibility for HCPs and patients through various ordering systems (e.g., EMRs, wholesalers, retail, online pharmacies)
Establish compliant and meaningful external partnerships, and explore new types of partnerships and business deals
Collaborate with internal cross-functional teams to achieve business objectives
Provide strategic oversight and guidance to the B2B team, ensuring alignment with overall business goals and fostering a high-performance culture
Bring innovative Trade Marketing solutions to grow core brands in the channel
Provide data intelligence and strategic initiatives to support decision-making and exceed business targets, including KPI tracking and performance dashboards
Lead, coach, and develop the B2B team, fostering a culture of accountability, innovation, and operational excellence while ensuring compliance and efficient resource use
Report clear and accurate performance data
Develop robust plans and identify commercial opportunities for the company, utilizing the capability to analyze complex data and identify untapped opportunities
Determine the best approach to tap into these opportunities and drive business growth
Act as a senior advisor to leadership on B2B strategy and market dynamics, contributing to long-term planning and innovation

Skills

Business Development

Strategic Account Management

Leadership

Relationship Building

Strategic Planning

Sales Growth

Stakeholder Management

Team Mentoring

Pharmaceutical Sales

Healthcare Partnerships

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free